In prostate cancer, for example, the activity of the Nrf2/Keap1 system is modulated by upstream oncogenic signals, including KRAS and Myc, which influence its dual role in tumor suppression and progression depending on the cellular context [142]. This evidence concerns the gene NFE2L2 and neoplasm.